What could change its growth trajectory, and what would confirm it?
Rising order intake and order book are the near-term demand shift for Kirloskar Brothers—consolidated order intake grew 68% year on year to Rs 2,047.2 crore in Q2 FY27 on domestic and overseas orders, and the domestic order book reached Rs 2,926.4 crore in September 2026, up 29% year on year excluding the small pumps order book—with the stated FY27 double-digit growth plan and new product launches as commercial milestones to watch. Chairman and Managing Director Sanjay Kirloskar expressed confidence in double-digit FY27 revenue growth over FY26 for standalone businesses, a stated plan.
Product launches in FY 2025 added new borewell, openwell, and slurry series—KU7P, LEHR, JOS Ultra, and GFP—to the range.
Which risks could break the thesis, and what would warn of them?
The observable thesis risk for Kirloskar Brothers right now is the market's technical verdict, and momentum confirmation is the sign to watch; this is a market-read warning sign rather than an operating fact.
Margin pressure in Q2 FY27 stemmed from reduced contribution from the services business, traditionally its higher-margin segment. The international EBITDA margin reached 5.3% during Q2 FY27. Management pointed to commodity-cost pressure when discussing quarterly profitability.
What does the product do for its buyer, and how is it delivered?
Kirloskar Brothers sells engineered, industrial, agriculture and domestic pumps, valves, and hydro turbines as global fluid-management solutions in the pumps and valves category, delivered both as products and as turnkey fluid-handling projects for irrigation, power, process, water supply and sewerage, small hydel, and protective surface coating work.
FY 2025 added the KU7P, LEHR, JOS Ultra, and GFP series across borewell, openwell, and slurry pump applications.

Kirloskar Brothers makes industrial, agriculture and domestic pumps, valves plus hydro turbines for large infrastructure projects.